TRPM8 Modulator Compounds for Cold Sensation Without Irritation

The patent applies parameter changes by developing novel chemical compounds with modified molecular structures that alter the interaction profile with TRPM8 receptors. The new compounds (e.g., compounds of formula I with specific R1-R6 substituents) are designed to change binding affinity and selectivity parameters, achieving cold sensation activation while reducing off-target effects that cause irritation. This is evidenced by the systematic variation of substituent groups in the claimed compounds to optimize the balance between efficacy and safety.

The patent applies local quality by designing compounds with specific functional groups at defined positions (R1-R6 substituents) that create localized interaction zones with the TRPM8 receptor. This allows selective activation of cold-sensing neurons while avoiding activation of other ion channels that mediate anesthetic effects. The structured approach of modifying specific positions in the molecular framework enables precise control over the quality and intensity of sensory activation without proportionally increasing harmful effects.

The patent applies composite materials by creating molecules that combine multiple functional elements within a single molecular structure. The compounds of formula I integrate a core heterocyclic or carbocyclic framework with various substituent groups (R1-R6) that collectively provide enhanced potency, improved solubility characteristics, and optimized volatility profiles. This molecular composite approach allows simultaneous optimization of multiple pharmacokinetic and pharmacodynamic properties that cannot be achieved with simpler structures.